Wuxi Further Pharmaceutical Co.,Ltd

Wuxi Further Pharmaceutical Co.,Ltd

Further Pharmaceutical Co.,Ltd (www.further-pharm.com) is an innovation-driven and service-oriented biopharmaceutical company with global operations that develops and manufactures specialty and generic drugs, pharmaceutical intermediates and APIs. Subsidiary companies include Jiangsu Further Pharmaceutical Co.,Ltd, Wuxi Further Pharmaceutical Co.,Ltd, and Canada Further Pharma Inc.

• Business Type: Manufacturer
• Main Products: Uracil, Folic Acid, Thymine, 5-Bromouracil, Fluorocytosine, Acacetin, Theacrine
• Main Markets: America, Africa, Asia, Europe
• Established year: 2018
• Total Annual Revenue: US$10 Million - US$50 Million
• Export Percentage: 61% - 70%
• Location: Block C5-310, #1699 Huishan Avenue, Wuxi 214174, Jiangsu Province, China
• Phone Number : Membership Required
• Country: China
• Key Products: Uracil, Folic Acid, Thymine, 5-Bromouracil, Fluorocytosine, Acacetin, Theacrine